Metoclopramide Use in Very Low Birth Weight Newborns

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

During the first 7 days of life very small babies will receive the drug metoclopramide or a salt solution through an intravenous line. They will also begin to receive a very small amount of breast milk or formula within the first 72 hours of life, in addition toother nourishment that is provided by an intravenous line, according to standard hospital procedure. We think that the babies who receive the medication may reach full oral feeds than babies who receive the salt solution.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lawson Health Research Institute
• Treatments: Metoclopramide

Criteria

Inclusion Criteria:

• birth weight 500 to 1,250g

• clinically stable

• no contraindications to initiating minimal enteral feeding

Exclusion Criteria:

• birth weight > 1,250g

• clinically unstable

• any major congenital anomaly

• significant GI pathology

• severe IUGR

• cholestasis